Justin Wilford1, Kathryn Osann2, Susie Hsieh2, Bradley Monk3, Edward Nelson4, Lari Wenzel5. 1. Program in Public Health, University of California, Irvine, Irvine, CA, USA. 2. Department of Medicine, Division of Hematology/Oncology, University of California, Irvine, Irvine, CA, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, USA. 3. Creighton University School of Medicine at St. Joseph's Hospital & Medical Center, Phoenix, AZ, USA. 4. Department of Medicine, Division of Hematology/Oncology, University of California, Irvine, Irvine, CA, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, USA; Institute for Immunology, University of California, Irvine, Irvine, CA, USA. 5. Program in Public Health, University of California, Irvine, Irvine, CA, USA; Department of Medicine, Division of Hematology/Oncology, University of California, Irvine, Irvine, CA, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, USA. Electronic address: LWenzel@uci.edu.
Abstract
OBJECTIVES:Cervical cancer patients are at high risk for emotional distress. In this study we evaluate the PROMIS emotional distress-Depression and -Anxiety Short Forms for assessing depression and anxiety in a cervical cancer population. METHODS: A 15-item questionnaire was used in a cervical cancer biobehavioral randomized clinical trial, testing psychosocial telephone counseling (PTC) against usual care (UC). It was administered to 204 patients prior to randomization, four months post-enrollment, and nine months post-enrollment, together with legacy measures of depression. The short forms were evaluated in patients participating in this study over three time points for internal consistency, convergent validity, and responsiveness to change over time. RESULTS: Overall, 45% and 47% of patients scored in the moderate to severe range for anxiety and depression, respectively. Internal consistency coefficients were ≥ 0.95 at baseline, 4 months, and 9 months for depression and anxiety. The average inter-item correlation was 0.65 and 0.73 at baseline assessment for depression and anxiety, respectively. The depression short form T-score was correlated with legacy distress scales ranging from 0.44-0.76, and the anxiety short form ranging from 0.45-0.78. The depression short form demonstrated sensitivity to change as patients randomized to the counseling intervention reported greater improvement over time in depression (p = 0.014), and a nonsignificant improvement in anxiety, compared to the patients receiving usual care. CONCLUSIONS: The PROMIS depression and anxiety short forms reliably and validly assess cervical cancer-specific emotional distress, capture salient features of distress in this population, and perform as well or better than legacy measures.
RCT Entities:
OBJECTIVES:Cervical cancerpatients are at high risk for emotional distress. In this study we evaluate the PROMIS emotional distress-Depression and -Anxiety Short Forms for assessing depression and anxiety in a cervical cancer population. METHODS: A 15-item questionnaire was used in a cervical cancer biobehavioral randomized clinical trial, testing psychosocial telephone counseling (PTC) against usual care (UC). It was administered to 204 patients prior to randomization, four months post-enrollment, and nine months post-enrollment, together with legacy measures of depression. The short forms were evaluated in patients participating in this study over three time points for internal consistency, convergent validity, and responsiveness to change over time. RESULTS: Overall, 45% and 47% of patients scored in the moderate to severe range for anxiety and depression, respectively. Internal consistency coefficients were ≥ 0.95 at baseline, 4 months, and 9 months for depression and anxiety. The average inter-item correlation was 0.65 and 0.73 at baseline assessment for depression and anxiety, respectively. The depression short form T-score was correlated with legacy distress scales ranging from 0.44-0.76, and the anxiety short form ranging from 0.45-0.78. The depression short form demonstrated sensitivity to change as patients randomized to the counseling intervention reported greater improvement over time in depression (p = 0.014), and a nonsignificant improvement in anxiety, compared to the patients receiving usual care. CONCLUSIONS: The PROMIS depression and anxiety short forms reliably and validly assess cervical cancer-specific emotional distress, capture salient features of distress in this population, and perform as well or better than legacy measures.
Authors: J Zabora; K BrintzenhofeSzoc; P Jacobsen; B Curbow; S Piantadosi; C Hooker; A Owens; L Derogatis Journal: Psychosomatics Date: 2001 May-Jun Impact factor: 2.386
Authors: Roxanne E Jensen; Arnold L Potosky; Carol M Moinpour; Tania Lobo; David Cella; Elizabeth A Hahn; David Thissen; Ashley Wilder Smith; Jaeil Ahn; George Luta; Bryce B Reeve Journal: J Clin Oncol Date: 2017-04-20 Impact factor: 44.544
Authors: Richard T Penson; Helen Q Huang; Lari B Wenzel; Bradley J Monk; Sharon Stockman; Harry J Long; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J A Reid; Mario M Leitao; Michael Method; Helen Michael; Krishnansu S Tewari Journal: Lancet Oncol Date: 2015-01-29 Impact factor: 41.316
Authors: Lari Wenzel; Israel DeAlba; Rana Habbal; Brenda Coffey Kluhsman; Diane Fairclough; Linda U Krebs; Hoda Anton-Culver; Ross Berkowitz; Noreen Aziz Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Krishnansu S Tewari; Michael W Sill; Harry J Long; Richard T Penson; Helen Huang; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J Reid; Mario M Leitao; Helen E Michael; Bradley J Monk Journal: N Engl J Med Date: 2014-02-20 Impact factor: 91.245
Authors: David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon Journal: Qual Life Res Date: 2014-06-18 Impact factor: 4.147
Authors: Howard P Greenwald; Ruth McCorkle; Kathy Baumgartner; Carolyn Gotay; Anne Victoria Neale Journal: J Cancer Surviv Date: 2014-04-05 Impact factor: 4.442
Authors: Anand S Iyer; J Nicholas Dionne-Odom; Stephanie M Ford; Sheri L Crump Tims; Elizabeth D Sockwell; Nataliya V Ivankova; Cynthia J Brown; Rodney O Tucker; Mark T Dransfield; Marie A Bakitas Journal: Ann Am Thorac Soc Date: 2019-08
Authors: Priscilla Gates; Karla Gough; Haryana Dhillon; Carlene Wilson; Eliza Hawkes; Vincent Dore; Yuliya Perchyonok; Christopher C Rowe; Adam K Walker; Janette L Vardy; Michiel de Ruiter; Meinir Krishnasamy Journal: BMJ Open Date: 2020-09-29 Impact factor: 2.692